Can-Fite BioPharma Ltd. reported a net loss of $9.8M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025.
Annual figures, oldest first. Point at a bar to read its period.
CANF Net Income by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Can-Fite BioPharma Ltd. financials
Frequently Asked Questions
Can-Fite BioPharma Ltd. reported a net loss of $9.8M in fiscal year 2025.
Can-Fite BioPharma Ltd. (CANF) reported a $7.9M net loss in fiscal year 2024 and a $9.8M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 11 fiscal years this page covers, Can-Fite BioPharma Ltd. (CANF) net income went from -$6.5M in fiscal year 2015 to -$9.8M in fiscal year 2025.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Can-Fite BioPharma Ltd. (CANF) reported on that line in every period on record.